
The Mesothelioma Center News – Page 17
-
Research & Clinical TrialsFor some patients, the future of mesothelioma cancer treatment may hinge on a pair of phase I clinical trials that opened earlier this…
-
Legislation & Litigation
Asbestos Abatement Laws Being Enforced
Cities and counties throughout the country are paying the price for failing to adhere to the tightening safety protocols that cover the handling and… -
Research & Clinical Trials
Novel Clinical Trial Helping Late-Stage Mesothelioma Patients
Late-stage patients with pleural mesothelioma have survived longer than anticipated — with good quality of life — in a phase I clinical… -
Asbestos Exposure & Bans
Sudden Rise in Asbestos Imports as Ban Draws Closer
Importation of raw chrysotile asbestos into the United States increased dramatically earlier this year, despite the growing movement toward tighter regulation and a potential… -
Research & Clinical Trials
Carbone: Building the Guide to BAP1 Mutation in Mesothelioma
Over the years, I have “collected” many families affected by the BAP1 cancer syndrome, a novel medical condition we discovered in 2011. Pathogenic germline… -
Research & Clinical Trials
Targeted Therapy Making Progress with Pleural Mesothelioma
Future treatment of pleural mesothelioma cancer continued its move toward a more personalized, targeted approach with the latest results from a multi-center clinical… -
Veterans & Military
Veterans Getting Closer to Justice at Camp Lejeune
Veterans and their families who were exposed to the contaminated drinking water at Marine Corps Base Camp Lejeune in North Carolina may soon find… -
Asbestos Exposure & Bans
Increasing Numbers of Women Dying from Malignant Mesothelioma
The number of women dying annually from malignant mesothelioma climbed by 25% over the past two decades, despite a nationwide drop in the… -
Asbestos Exposure & Bans
EPA Proposes Stricter Asbestos Reporting
The United States Environmental Protection Agency has proposed a new rule that would require much stricter reporting and record keeping for all uses… -
Research & Clinical Trials
New Mesothelioma Immunotherapy Clinical Trial Opens at MD Anderson
The acclaimed MD Anderson Cancer Center in Houston is opening a phase II clinical trial involving a new immunotherapy drug aimed specifically at…